Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Bonginelli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|March 12, 2004
Antiangiogenic strategies, compounds, and early clinical results in breast cancerAlessandro Morabito, Roberta Sarmiento, Paola Bonginelli, et al.
Journal of Translational Medicine|December 17, 2003
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)Maurizio Provenzano, Simone Mocellin, Paola Bonginelli, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlatesGiampietro Gasparini, Sabrina Meo, Giuseppe Comella, et al.
Oncology Reports|July 6, 2006
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancerAlessandro Morabito, Raffaele Longo, Domenico Gattuso, et al.
Breast Cancer Research and Treatment|December 7, 2010
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancerDino Amadori, Rosella Silvestrini, Mario De Lena, et al.
Anticancer Research|November 2, 2007
Colorectal cancer treatment in elderly patients: results of a retrospective analysis addressed to the chiefs of medical oncology units in ItalyLara Maria Pasetto, Cristina Falci, Umberto Basso, et al.
Anticancer Research|August 30, 2008
Adjuvant treatment for elderly patients with colon cancer. An observational studyLara Maria Pasetto, Cristina Falci, Umberto Basso, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|March 12, 2004
Antiangiogenic strategies, compounds, and early clinical results in breast cancerAlessandro Morabito, Roberta Sarmiento, Paola Bonginelli, et al.
Journal of Translational Medicine|December 17, 2003
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)Maurizio Provenzano, Simone Mocellin, Paola Bonginelli, et al.
Recenti Progressi in Medicina|December 20, 2002
[Innovative treatment in oncology]Barbara Capaccetti, Paola Bonginelli, Roberta Sarmiento, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlatesGiampietro Gasparini, Sabrina Meo, Giuseppe Comella, et al.
Oncology Reports|July 6, 2006
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancerAlessandro Morabito, Raffaele Longo, Domenico Gattuso, et al.
Breast Cancer Research and Treatment|December 7, 2010
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancerDino Amadori, Rosella Silvestrini, Mario De Lena, et al.
Anticancer Research|November 2, 2007
Colorectal cancer treatment in elderly patients: results of a retrospective analysis addressed to the chiefs of medical oncology units in ItalyLara Maria Pasetto, Cristina Falci, Umberto Basso, et al.
Anticancer Research|August 30, 2008
Adjuvant treatment for elderly patients with colon cancer. An observational studyLara Maria Pasetto, Cristina Falci, Umberto Basso, et al.
Pageof 1